Cambridge Heart, Inc.
| OTC Markets: CAMH
Cambridge Heart, Inc. is a healthcare company. It is engaged in the research, development and commercialization of products for the non-invasive diagnosis of cardiac disease. The company uses technologies that address problems in cardiac diagnosis including the identification of those at risk of sudden cardiac arrest. Its diagnostic products incorporate its proprietary technology for the measurement of Microvolt T-Wave Alternans. Cambridge Heart was founded by Jeffrey M. Arnold on January 16, 1990 and is headquartered in Tewksbury, MA.